Fully automatic glycated hemoglobin analyzer Hb NEXT

for clinical diagnosticfor anemiafor diabetes

Overview
Hb NEXT is a reversed‑phase cation‑exchange HPLC analyzer designed for precise quantification of HbA1c, HbA2, HbF and characterization of major hemoglobin variants. The system supports two analysis modes (Variant mode for routine HbA1c; Thalassemia mode for hemoglobinopathy screening) and three selectable working methods to match laboratory workflows.

Key features

• Fully automated reversed‑phase cation‑exchange HPLC combining accurate quantification and variant detection with high throughput.
• Two analysis modes using the same column and reagent containers: Variant mode (HbA1c) and Thalassemia mode (hemoglobinopathies). Mode switching is operator‑controlled and does not require column or reagent change.
• No sample preparation required; closed‑tube sampling for operator safety.
• Long column lifetime (≥ 6000 tests).
• Loader options: 50 or 110 sample tubes, both with STAT capability.
• Reagent duplicate loading with automatic switching and lot compatibility for eluents and column.

Full traceability, flexibility and automation

• Automatic sample type recognition with two rack versions: whole blood or pre‑hemolysed; supports anemic samples.
• Automatic sample identification by tube rotation and internal barcode scanning.
• Sample mixing by tube inversion.
• Semi‑automated preparation of calibrators, controls and pre‑hemolysed samples.
• Reagent identification and traceability via QR code reading.
• Results traceable to the IFCC reference method and reported in IFCC (mmol/mol) and NGSP (%).

User friendly with extended autonomy

• No column or reagent change required when switching modes.
• Minimal operator intervention; no daily maintenance routine.
• Closed‑tube sampling enhances operator safety.
• Extended autonomy through duplicate reagent loading and automatic management.
• Loader options: 50 or 110 samples plus STAT.

Product codes
55607 — Hb NEXT Analyzer - 50 sample loader — 1 pcs
55943 — Hb NEXT Analyzer - 110 sample loader — 1 pcs
55599 — Hb NEXT Eluent A — 1x800 mL
55600 — Hb NEXT Eluent B — 1x800 mL
55601 — Hb NEXT Eluent C — 1x800 mL
55602 — Hb NEXT Eluent D — 1x800 mL
55603 — Hb NEXT Haemolysis solution H — 1x2500 mL
55604 — Hb NEXT Column — 1 pcs
55605 — Hb NEXT HbA1c Control — 2x0,1 mL
55606 — Hb NEXT HbA1c Calibrator — 2x0,1 mL
56149 — ß-THALASSAEMIA & HbA1c Calibrator — 2x0,1 mL
56150 — ß-THALASSAEMIA & HbA1c Control Material — 2x0,1 mL

Brochure / White paper
Product brochure and white paper available for download (PDF documents associated to the product).

Caractéristiques / spécifications techniques

• Intended use: Quantification of HbA1c, HbA2, HbF and characterization of Hb variants.
• Samples: Human whole venous blood and pre‑hemolysed samples.
• Measurement principle: HPLC - Reversed‑phase cation exchange.
• Measurement unit: Peak calibration with results in SI units (mmol/mol) and conversion to NGSP (%) via the IFCC master equation.
• Measurement resolution: 0.01 mmol/mol | 0.01%.
• Quantitative range: HbA1c: 9‑195 mmol/mol (3‑20%); HbF: 0‑100%; HbA2: 0‑8%; Hb variants: 0‑100%.
• Processing speed: Variant mode: 60 s/sample; Thalassemia mode: 380 s/sample.
• Warm‑up time: < 10 minutes.
• Minimum sample volume: 1 mL (standard whole blood tubes); 300 µL (pre‑diluted EP tubes).
• Sample consumption (whole blood): Variant mode: 3 µL; Thalassemia mode: 7 µL.
• Sample container: Whole blood tube (12–15 mm Ø × 75–100 mm H). With mixing active: 12.3–13.2 mm Ø × 75–85 mm H.
• Column lifetime: ≥ 6000 tests.
• Sample identification: Internal barcode reader.
• Sampler capacity: 50 loader: 50 samples + STAT; 110 loader: 110 samples + STAT.
• Display and printer: 10.1" TFT color LCD and thermal printer.
• Power supply: AC 100–240 V, 50–60 Hz, 250 VA.
• Dimensions & weight: 50 loader — 722×730×729 mm (L×W×H), 66 kg; 110 loader — 722×873×729 mm, 73 kg.
• Operating environment: Temperature 10–30 °C; humidity 20–80% R.H. (no condensation).
• Connectivity: LIS via RS‑232, RJ45 Ethernet, bidirectional protocol.